As of August 28, 2026, DiaMedica Therapeutics Inc. (DMAC) has a DilutionWatch DilutionScore of 37/100, rated MEDIUM dilution risk. DiaMedica Therapeutics Inc. has a market capitalization of $322.76M, 53.93M shares outstanding, 98 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for DMAC.
Market Data
Market Cap$322.76M
Shares Outstanding53.93M
Float28.60M
Cash$43.50M
DebtN/A
Short InterestN/A
Institutional Holdings
QoQ: ↑ 9.3% shares (2026Q1 vs prior)
98 institutional holders · 13.52M shares
#1
COOPERMAN LEON G
2.02M shares
#2
BlackRock, Inc.
1.86M shares
#3
MORGAN STANLEY
1.23M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest5.20M
Days to Cover27.4
% of Float18.2%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track DMAC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DMAC — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for DMAC
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.